Publications
TriStem has published details of its retrodiferentiation methodology as well as studies which confirm that the process creates stem cells and that these have a therapeutic benefit in peer-reviewed journals.
2017
A review of epimorphic regeneration and retrodifferentiation
This article reviews the ability of cells in nature to reverse differentiate and regenerate tissues and organs, as well as the process of retrodifferentiation which turns human white blood cells into stem cells, which can be grown into complex tissues or body parts.
2012
Treating patients with aplastic anaemia
Four patients were treated with a single infusion of stem cells created from their own white blood cells using TriStem’s technology. Two of the four patients with aplastic anaemia become transfusion independent for more than seven years.
2006
A review article on the therapeutic potential for stem cells
This article explores the opportunities for treating diseases with pluripotent stem cells.
Treating patients with beta thalassemia
Twenty one patients with beta thalassemia were treated with a single infusion of stem cells created from their own white blood cells using TriStem’s technology. Over six months after treatment, the average number of transfusions was reduced and blood iron levels reduced.
2003
Creation of stem cells from adults cells
This paper describes the method by which TriStem is able to create stem cells from adult blood cells.
Creating a new blood system in a mouse using human stem cells made by Retrodifferentiation
Stem Cells were made from Human blood cells using TriStem’s Retrodifferentiation method and infused into mice. The cells engrafted in the bone marrow and produced the full range of blood cells. When analysed, these cells had human genes in them showing that TriStem’s cells can even work in an animal model.